Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
The Board of Directors of Helmerich & Payne, Inc. (NYSE: HP) announced today that Chief Executive Officer (CEO) John Lindsay ...
Federal health officials on Wednesday expanded an outbreak of infant botulism tied to recalled ByHeart baby formula to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback